Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Biodesix's Amortization of Deferred Charges history spans 3 years, with the latest figure at $41000.0 for Q1 2021.

  • For Q1 2021, Amortization of Deferred Charges rose 13.89% year-over-year to $41000.0; the TTM value through Mar 2021 reached $147000.0, changed N/A, while the annual FY2020 figure was $144000.0, 0.0% changed from the prior year.
  • Amortization of Deferred Charges reached $41000.0 in Q1 2021 per BDSX's latest filing, up from $35000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $41000.0 in Q1 2021 to a low of $35000.0 in Q4 2019.
  • Average Amortization of Deferred Charges over 3 years is $36750.0, with a median of $35500.0 recorded in 2019.
  • Peak YoY movement for Amortization of Deferred Charges: changed 0.0% in 2020, then grew 13.89% in 2021.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then increased by 17.14% to $41000.0 in 2021.
  • Per Business Quant, the three most recent readings for BDSX's Amortization of Deferred Charges are $41000.0 (Q1 2021), $35000.0 (Q4 2020), and $36000.0 (Q1 2020).